These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2631826)

  • 21. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M; Altshuler J; Testani JM
    Pharmacotherapy; 2016 Aug; 36(8):843-51. PubMed ID: 27321568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose furosemide in the treatment of refractory congestive heart failure.
    Gerlag PG; van Meijel JJ
    Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Cosmai L; Meloni F; Campana C; Rampino T; Monti C; Tavazzi L; Dal Canton A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2013-9. PubMed ID: 17298996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
    Vitolo E; Segalini G; Carini L; Castini D; Moreo A; Mazzola C; Segagni S; Villa G; Salvadeo A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):327-34. PubMed ID: 3209280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D
    Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe electrolyte disturbances associated with metolazone and furosemide.
    Black WD; Shiner PT; Roman J
    South Med J; 1978 Apr; 71(4):380-1, 385. PubMed ID: 635611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
    Marenzi G; Guazzi M; Lauri G; Perego GB; Sganzerla P; Agostoni P
    Cardiologia; 1994 Nov; 39(11):763-72. PubMed ID: 7736475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
    Salahudin M; Shah H; Jan MU; Altaf A
    J Pak Med Assoc; 2019 Dec; 69(12):1794-1799. PubMed ID: 31853105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
    Nassiacos D; Meloni S
    Ital Heart J; 2005 May; 6 Suppl 1():51S-65S. PubMed ID: 15945300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metolazone addition on furosemide resistant cases of edema.
    Kshirsagar NA; Gupta KC; Paul T; Shah BP; Vora KK; Sanghvi B; Acharya VN; Mehta JM; Sheth UK
    J Assoc Physicians India; 1978 Oct; 26(10):915-23. PubMed ID: 750570
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.